Medicare Part D coverage · cysteamine · RxCUI 2284514

cysteamine 300 MG Delayed Release Oral Granules [Procysbi]

Per the CMS 2026 Part D formulary file, cysteamine 300 MG Delayed Release Oral Granules [Procysbi] is covered by 39 Medicare Part D plans (0.8% of enrollable products), averaging Tier 5, with prior authorization required on 100% of covering formularies.

0.8%
Plan coverage
39
Plans covering
T5
Avg tier
100%
Prior auth required

Verify with CMS →

Important: Drug coverage and costs vary by plan and location. Verify coverage directly with your Medicare plan before filling a prescription. This is informational data only and should not replace advice from your healthcare provider or pharmacist.

What the CMS Formulary Data Shows for cysteamine 300 MG Delayed Release Oral Granules [Procysbi]

Per the CMS 2026 Part D formulary file, cysteamine 300 MG Delayed Release Oral Granules [Procysbi] (RxNorm concept RXCUI 2284514, generic name cysteamine) appears on 5 distinct formulary files spanning 39 Medicare Part D plan offerings - 0.8% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 5 to Tier 5, with a cross-plan average of Tier 5.

Real-world access to cysteamine 300 MG Delayed Release Oral Granules [Procysbi] depends on utilization management as much as tier placement: 100% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.

Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 30 Part D beneficiaries filled cysteamine 300 MG Delayed Release Oral Granules [Procysbi] in 2023, with total plan-and-beneficiary spending of $2,301,078 and an average per-beneficiary annual cost of $76,702.62. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry cysteamine 300 MG Delayed Release Oral Granules [Procysbi] today.

Coverage Details

Formularies covering
5
Plans covering
39
Coverage rate
0.8%
Tier range
Tier 5, Specialty
Average tier
Tier 5, Specialty

Restrictions

Prior authorization required
100% of formularies
Step therapy required
0% of formularies
Quantity limits
0% of formularies

2023 Medicare Spending

Beneficiaries
30
Total spending
$2,301,078
Avg per beneficiary
$76,702.62

Tier Distribution Across Plans

39 plans
Tier 5, Specialty

Standalone Drug Plans (PDP) Covering cysteamine 300 MG Delayed Release Oral Granules [Procysbi]

2 standalone prescription drug plans include this drug.

Plan Insurer Tier PA ST Premium States
Blue Rx PDP Complete (PDP) HM Health Insurance Company T5 Yes No $164.80 -
Blue Rx PDP Plus (PDP) HM Health Insurance Company T5 Yes No $193.20 -

Medicare Advantage Plans (MA-PD) Covering cysteamine 300 MG Delayed Release Oral Granules [Procysbi]

37 Medicare Advantage plans with Part D drug coverage include this drug.

Plan Insurer Tier PA Premium States
Medicare BlueEssential (PPO) Excellus Health Plan, Inc. T5 Yes $0 NY
Medicare BlueActive (PPO) Excellus Health Plan, Inc. T5 Yes $0 NY
Medicare BlueVital (PPO) Excellus Health Plan, Inc. T5 Yes $0 NY
Univera SeniorChoice Basic (HMO) Excellus Health Plan, Inc. T5 Yes $0 NY
Univera SeniorChoice Extra (HMO) Excellus Health Plan, Inc. T5 Yes $0 NY
Medicare Blue Choice Core (HMO) Excellus Health Plan, Inc. T5 Yes $0 NY
Univera Medicare Dual (HMO D-SNP) Excellus Health Plan Community Care LLC T5 Yes $0 NY
Medicare Blue Dual (HMO D-SNP) Excellus Health Plan Community Care LLC T5 Yes $0 NY
CDPHP $0 Medicare Rx (HMO) Capital District Physicians' Health Plan, Inc. T5 Yes $0 NY
UPMC for Life HMO Rx Choice (HMO) Upmc Health Plan, Inc. T5 Yes $3.90 OH, PA
UPMC for Life HMO Deductible Rx (HMO) Upmc Health Plan, Inc. T5 Yes $18.10 OH, PA
UPMC for Life PPO Rx Choice (PPO) Upmc Health Network, Inc. T5 Yes $25.00 PA
Univera SeniorChoice Core (PPO) Excellus Health Plan, Inc. T5 Yes $33.00 NY
UPMC for Life PPO High Deductible Rx (PPO) Upmc Health Network, Inc. T5 Yes $33.00 PA
UPMC for Life HMO Rx (HMO) Upmc Health Plan, Inc. T5 Yes $33.70 OH, PA
Univera SeniorChoice Advanced (HMO-POS) Excellus Health Plan, Inc. T5 Yes $36.90 NY
UPMC for Life PPO Rx Enhanced (PPO) Upmc Health Network, Inc. T5 Yes $42.70 PA
Medicare BlueClassic (PPO) Excellus Health Plan, Inc. T5 Yes $51.00 NY
Security Blue HMO-POS Standard (HMO-POS) Highmark Choice Company T5 Yes $51.80 PA
Univera SeniorChoice Secure (HMO-POS) Excellus Health Plan, Inc. T5 Yes $54.90 NY
Show the next 17 plans
Medicare BlueBalanced (PPO) Excellus Health Plan, Inc. T5 Yes $55.00 NY
Medicare Blue Choice Prime (HMO) Excellus Health Plan, Inc. T5 Yes $55.00 NY
Univera SeniorChoice Value Plus (HMO-POS) Excellus Health Plan, Inc. T5 Yes $58.60 NY
Medicare BlueEnhanced (PPO) Excellus Health Plan, Inc. T5 Yes $70.30 NY
Medicare BluePlus (PPO) Excellus Health Plan, Inc. T5 Yes $86.40 NY
UPMC for Life HMO Rx Enhanced (HMO) Upmc Health Plan, Inc. T5 Yes $93.40 OH, PA
Freedom Blue PPO Select (PPO) Highmark Senior Health Company T5 Yes $95.70 PA
Security Blue HMO-POS Deluxe (HMO-POS) Highmark Choice Company T5 Yes $95.90 PA
Freedom Blue PPO Standard (PPO) Highmark Senior Health Company T5 Yes $98.20 PA
CDPHP Clear Rx (HMO) Capital District Physicians' Health Plan, Inc. T5 Yes $100.00 NY
Freedom Blue PPO Select (PPO) Highmark Senior Health Company T5 Yes $115.70 PA
Freedom Blue PPO Deluxe (PPO) Highmark Senior Health Company T5 Yes $122.40 PA
CDPHP Choice Rx (HMO) Capital District Physicians' Health Plan, Inc. T5 Yes $135.00 NY
UPMC for Life PPO Rx Enhanced (PPO) Upmc Health Network, Inc. T5 Yes $140.00 PA
Freedom Blue PPO Classic (PPO) Highmark Senior Health Company T5 Yes $140.90 PA
Freedom Blue PPO Classic (PPO) Highmark Senior Health Company T5 Yes $145.40 PA
Medicare Blue Choice Optimum (HMO-POS) Excellus Health Plan, Inc. T5 Yes $146.00 NY

Frequently Asked Questions

Is cysteamine 300 MG Delayed Release Oral Granules [Procysbi] covered by Medicare Part D?

Yes, cysteamine 300 MG Delayed Release Oral Granules [Procysbi] is covered by 39 Medicare Part D plans (0.8% of all Part D formularies).

What tier is cysteamine 300 MG Delayed Release Oral Granules [Procysbi] on Medicare Part D plans?

cysteamine 300 MG Delayed Release Oral Granules [Procysbi] averages Tier 5 across Part D plans, ranging from Tier 5 to Tier 5.

Does cysteamine 300 MG Delayed Release Oral Granules [Procysbi] require prior authorization?

100% of Part D formularies require prior authorization for cysteamine 300 MG Delayed Release Oral Granules [Procysbi]. Step therapy: 0%. Quantity limits: 0%.

How much does Medicare spend on cysteamine 300 MG Delayed Release Oral Granules [Procysbi]?

In 2023, total Medicare Part D spending on cysteamine 300 MG Delayed Release Oral Granules [Procysbi] was $2,301,078, covering 30 beneficiaries. The average spend per beneficiary was $76,702.62.

Nationwide similar Part D drugs

Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.

Data sourced from the Centers for Medicare & Medicaid Services (CMS). See our methodology for details. Retrieved and formatted by PlainMedicare